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Bath-PUVA therapy improves impaired resting regulatory T cells and 
increases activated regulatory T cells in psoriasis 
(PUVA バス療法は乾癬患者において低下した resting の制御性 T 細胞
(rTreg)を改善し、そして活性化制御性 T 細胞(aTreg) を増加させる) 
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Background: Bath-psoralen plus ultraviolet light A (PUVA) therapy is an effective, safe, 
and inexpensive treatment for psoriasis. Psoriasis might be due to an unbalanced ratio 
of Th17 cells and regulatory T cells (Treg). The Treg functional ratio is significantly 
lower in patients with psoriasis compared with controls and is inversely correlated with 
the Psoriasis Area and Severity Index score1). We previously reported that bath-PUVA 
therapy significantly increases the number of Treg and restores Treg function to almost 
normal in most patients with psoriasis1) 2).  
Objectives:  
Miyara et al. reported that CD4+ CD25+ Foxp3+ T cells can be divided into three subsets 
using the cell surface marker CD45RA3). CD4+ CD25+ CD45RA-, and Foxp3high 
lymphocytes are called activated Treg (aTreg), and have the strongest suppressive 
activity. CD4+ CD25+ CD45RA+ and Foxp3low lymphocytes are called resting Treg 
(rTreg), and have mild suppressive activity compared with aTreg. CD4+ CD25+ 
CD45RA- and Foxp3low lymphocytes are called non-suppressive T cells (non-Treg), and 
have no suppressive activity. We examined the effects of bath-PUVA therapy on three 
distinct Foxp3+ subsets. 
Methods: We enrolled 15 patients with psoriasis and 11 healthy controls. We examined 
aTreg, rTreg, and cytokine-secreting non-suppressive T cells in peripheral blood 
obtained from the psoriasis patients before and after every fifth bath-PUVA therapy 
session.  
Results: Levels of aTreg, which are considered to have the strongest suppressive 
activity in patients with psoriasis, were significantly increased in the early bath-PUVA 
therapy sessions, and then diminished. Levels of rTreg were lower in psoriasis patients 
than in healthy controls, and increased during bath-PUVA therapy.  
Conclusions: Bath-PUVA therapy induced aTreg and rTreg concomitantly with an 
improvement in the psoriatic lesions, suggesting a mechanism for the effectiveness of 
bath-PUVA therapy for psoriasis patients. 
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